Drug use represents a significant burden to public health through disease, disability and
social problems, and policy makers are becoming increasingly interested in how to develop …

Background Many systematic reviews exist on interventions to improve safe and effective
medicines use by consumers, but research is distributed across diseases, populations and …

In the context of pharmaceutical care, policy-makers repeatedly face the challenge of
balancing patient access to effective medicines with affordability and rising costs. With the …

Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …

Context Recent public outcry has highlighted the rising cost of prescription drugs worldwide,
which in several disease areas outpaces other health care expenditures and results in a …

Background Pharmaceutical costs are the fastest-growing health-care expense in most
developed countries. Higher drug costs have been shown to negatively impact patient …

This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational
use of medicines and at keeping pharmaceutical spending under control. Policy makers are …

All European countries are facing growing pharmaceutical expenditure, particularly in public
expenditure [3] given that Europe has a comparatively higher coverage of publicly funded …

OBJECTIVE: Review the literature on the impact of policies designed to enhance uptake of
generic medicines in low and middle income countries (LMICs). METHODS: We searched …

Although economic theory indicates that it should not be necessary to intervene in the
generic drug market through price regulation, most EU countries intervene in this market …